Policy | December 03, 2021
Over one lakh SARS-CoV-2 genomes sequenced till November
Union Minister Dr Jitendra Singh said a large number of Covid-19 bio-repositories and samples were made available to academia and industry
Union Minister Dr Jitendra Singh said a large number of Covid-19 bio-repositories and samples were made available to academia and industry
Oravax's vaccine technology is highly scalable for manufacturing and is easily transferable for wide scale logistical distribution, as there is no need for freezer storage
The country’s top heart transplant surgeon Dr. K.R Balakrishnan to be leading the programme for Jaslok
Maharashtra won the award for the highest number of deceased donors transplantations
Premas Biotech is the developer of the technology for the Covid-19 vaccine and a shareholder in Oravax Medical
Viyash has ten manufacturing facilities in India with a combined capacity of 2000 KL as well as one formulation facility in the US, and is now one of India’s leading mid-tier integrated API and formulation players
The Indian Pharmacopoeia Commission (IPC) has added 23 new impurities standards and 7 new Indian Pharmacopoeial Reference standards
The aim is to support Pharmacovigilance programme across the countries in the region
The initiative will engage adolescents and youth of India in decisions about their reproductive health
The US $ 192.5 mn US government contract will help fund the centre of excellence to boost the domestic supply of critically needed laboratory plastics
Subscribe To Our Newsletter & Stay Updated
